Home » Stocks » AVNS

Avanos Medical, Inc. (AVNS)

Stock Price: $46.55 USD 2.17 (4.89%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
Market Cap 2.23B
Revenue (ttm) 714.80M
Net Income (ttm) -27.20M
Shares Out 47.83M
EPS (ttm) -0.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $46.55
Previous Close $44.38
Change ($) 2.17
Change (%) 4.89%
Day's Open 45.29
Day's Range 44.44 - 46.72
Day's Volume 232,276
52-Week Range 19.46 - 53.61

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 1 week ago

Investor confidence is high in Avanos Medical (AVNS) stock, courtesy of its solid prospects.

PRNewsWire - 1 week ago

ALPHARETTA, Ga., Feb. 24, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Vi...

Zacks Investment Research - 2 weeks ago

Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the fourth quarter.

Zacks Investment Research - 2 weeks ago

Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.27% and 0.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 2 weeks ago

Shares of Avanos Medical (NYSE:AVNS) rose 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 17.65% year over year to $0.28, which...

Zacks Investment Research - 2 months ago

Investor confidence is high on Avanos Medical (AVNS), courtesy of solid prospects.

Zacks Investment Research - 3 months ago

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

PRNewsWire - 4 months ago

ALPHARETTA, Ga., Nov. 5, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in November: Conference:...

Zacks Investment Research - 4 months ago

Avanos Medical (AVNS) continued to gain from core Chronic Care segment in the third quarter.

Seeking Alpha - 4 months ago

Avanos Medical's (AVNS) CEO Joe Woody on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 4 months ago

Avanos Medical (AVNS) delivered earnings and revenue surprises of 50.00% and 11.94%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...

PRNewsWire - 4 months ago

ALPHARETTA, Ga., Nov. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2020 financial results. "Thanks to the work of our team and their focus on executio...

PRNewsWire - 4 months ago

ALPHARETTA, Ga., Oct. 27, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 202...

Zacks Investment Research - 5 months ago

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

PRNewsWire - 5 months ago

ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc.

PRNewsWire - 6 months ago

ALPHARETTA, Ga., Sept. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Zacks Investment Research - 6 months ago

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

PRNewsWire - 6 months ago

ALPHARETTA, Ga., Sept. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc.

PRNewsWire - 6 months ago

ALPHARETTA, Ga., Aug. 31, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Zacks Investment Research - 6 months ago

Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.

Seeking Alpha - 7 months ago

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 7 months ago

Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 7 months ago

ALPHARETTA, Ga., Aug. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.

Zacks Investment Research - 7 months ago

Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 9 months ago

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

PRNewsWire - 9 months ago

ALPHARETTA, Ga., May 28, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June: Conference: Jef...

Seeking Alpha - 9 months ago

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 9 months ago

Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.

Zacks Investment Research - 10 months ago

Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 11 months ago

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

Zacks Investment Research - 11 months ago

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 year ago

Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.

Zacks Investment Research - 1 year ago

Avanos (AVNS) gains from segmental contributions in Q4.

Seeking Alpha - 1 year ago

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 year ago

Avanos (AVNS) third-quarter results benefit from higher revenues and strong segmental performance.

Seeking Alpha - 1 year ago

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q3 2019 Results - Earnings Call Transcript

The Motley Fool - 1 year ago

Shares slump after the company reports weak third-quarter results and cuts guidance. Here's what investors need to know.

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) delivered earnings and revenue surprises of -6.25% and -5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the st...

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 year ago

Avanos (AVNS) second-quarter results benefit from higher revenues, strong segmental performance and expansion in margins.

Seeking Alpha - 1 year ago

Avanos Medical's (AVNS) CEO Joe Woody on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) delivered earnings and revenue surprises of 12.00% and -0.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Avanos (AVNS) Q1 results benefit from higher revenues, strong segmental performance and expansion in margins.

Seeking Alpha - 1 year ago

Avanos Medical, Inc. (AVNS) CEO Joseph Woody on Q1 2019 Results - Earnings Call Transcript

About AVNS

Avanos Medical operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devic... [Read more...]

Industry
Medical Devices
CEO
Joseph Woody
Employees
5,380
Stock Exchange
NYSE
Ticker Symbol
AVNS
Full Company Profile

Financial Performance

In 2020, Avanos Medical's revenue was $714.80 million, an increase of 2.47% compared to the previous year's $697.60 million. Losses were -$27.20 million, -40.74% less than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Avanos Medical stock is "Buy." The 12-month stock price forecast is 52.00, which is an increase of 11.71% from the latest price.

Price Target
$52.00
(11.71% upside)
Analyst Consensus: Buy